LBRX R&D Expense Growth
Lb Pharmaceuticals Inc · R&D Expense Growth
LBRX R&D Expense Growth
Latest reported-67.28%period ending
LBRX FY R&D Growth (YoY) (0.00% → -67.28%)
Latest values, visible window
High-resolution chart · PNG
LBRX r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -67.2783% | |
| 552.2753% | |
| 482.838% | |
| 0% |